Cleo Salisbury

Cleo Salisbury is a technical development team leader at Genentech, where she has led a variety of CMC programs ranging from ophtha to immuno-oncology, early to late stage development, traditional mAbs to ADCs, conjugates, and more.  Prior to joining Genentech in 2013, Cleo was a research scientist at Novartis Diagnostics.  She obtained her Ph.D. in Chemistry from UC Berkeley and did a postdoctoral fellowship with Ben Cravatt at the Scripps Research Institute.  She is passionate about delivering new medicines to patients, nerdy science, daily workouts and daily chocolate.